Status:
COMPLETED
Effects of Soy Isoflavones on Menopausal Hot Flashes
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Nichimo - Tokyo, Japan
Conditions:
Menopausal Symptoms
Eligibility:
FEMALE
38-65 years
Phase:
PHASE2
PHASE3
Brief Summary
Hot flashes occur in three quarters of menopausal women, and can negatively impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes...
Detailed Description
Hot flashes occur in 75% of menopausal women and impact quality of life. Interest has arisen in isoflavones, found in rich supply in soy products, as therapy for hot flashes. The effect of a daidzein-...
Eligibility Criteria
Inclusion
- No menstrual period for at least six months, Hot flashes at least four t imes per day, Ages 38-65
Exclusion
- Pregnant, BMI\>45, History of breast cancer or other estrogen dependent tumors, Abnormal uterine bleeding, Heart, renal, or liver disease, Diabetes, Women taking hormone replacement therapy or serotonin reuptake inhibitors, Women taking any dietary supplements for the treatment of hot flashes (ex. soy supplements, vitamin E, flaxseed, red clover extract) within the past 30 days
Key Trial Info
Start Date :
June 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2005
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT00179556
Start Date
June 1 2003
End Date
September 1 2005
Last Update
March 14 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215